Group Product Director; GPD), Access & Patient Marketing, Neuroscience Schizophrenia

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and Med Tech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at  As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:
Marketing Job Sub Function:
Product Management Job Category:
Professional All Job Posting Locations:
Titusville, New Jersey, United States of America

Job Description:

Johnson & Johnson is recruiting for a Group Product Director (GPD), Access & Patient Experience Marketing, Neuroscience Schizophrenia located in Titusville, NJ.

About Neuroscience Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Neuroscience team tackles the world’s toughest brain health challenges including multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, myasthenia gravis, epilepsy, major depressive disorder, bipolar disorder, schizophrenia, and autism.

This patient-focused team helps address some of the most complex diseases of our time. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at

Role Overview The Group Product Director (GPD), Access and Patient Experience Marketing, Neuroscience Schizophrenia will be accountable for shaping the U.S. brand access strategy, defining access-related field direction, and leading omnichannel promotion for access and customer experience across the long-acting injectable portfolio, comprised of INVEGA SUSTENNA®, INVEGA TRINZA®, and INVEGA HAFYERA. This leader will be accountable for anticipating and addressing the reimbursement, affordability, fulfillment, and treatment-setting barriers that may prevent appropriate patients from initiating, accessing, and remaining on treatment.

This GPD will also be responsible for all aspects of the brand patient experience including brand education to patients/caregivers and direct-to-consumer advertising. This leader will partner closely with the CAPLYTA® brand team to deliver a cohesive schizophrenia portfolio strategy. The role requires strong cross-functional influence, strategic leadership, and the ability to coach and develop a high-performing team. This GPD will report to the Director of Marketing, Neuroscience Schizophrenia.

• Coach and develop a high-performing team while fostering an inclusive culture and strengthening capabilities.
• Lead the development and execution of the U.S. brand access strategy and ensure access considerations are incorporated into positioning, forecasting, and annual business planning.
• Shape and execute access messaging, resources, and omnichannel initiatives to enhance customer and patient engagement and maximize brand performance.
• Create clarity for the field access strategy, execution expectations, and resource utilization in partnership with Sales Leadership, PECS, SCG, and HCP Marketing.
• Oversee critical engagements with targeted pharmacies, focusing on strategy and contracting.
• Deliver focused…